top of page
Profile
Join date: Mar 20, 2023
Posts (26)
Feb 11, 2025 ∙ 2 min
Laxxon's New Generation Levodopa/Carbidopa Treatment, LXM.5, Granted Funding by ESF Plus and the Free State of Thuringia
Laxxon's New Generation Levodopa/Carbidopa for Parkinson's Disease project, LXM.5, has been awarded a grant.
16
0
Feb 4, 2025 ∙ 3 min
Laxxon Medical Announces Positive Pilot PK Study Results for Advanced Levodopa/Carbidopa Asset for Parkinson’s Disease, LXM.5
[New York, New York] – Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug delivery...
190
0
Jan 8, 2025 ∙ 2 min
Laxxon Medical Announces Appointment of Two New Members to Board of Directors
New independent directors Christof Bircher and Nneka Ukpai bring significant expertise in business strategy, corporate finance and...
85
0
Laxxon Medical
Writer
More actions
bottom of page